Voyager Therapeutics Executives Sell Shares Amidst Market Volatility.

Voyager Therapeutics, Inc. (VYGR) recently disclosed that Chief Scientific Officer Carter Todd Alfred sold 3,525 shares at a price of $3.85 per share on February 10, 2026. Additionally, Director, President, and CEO Sandrock Alfred sold 12,192 shares at $3.78 per share on the same date, while COO and CBO Swartz Robin sold 4,569 shares at $3.85 per share on February 10, 2026.